Abstract:Background: Prostate cancer remains the second deadliest cancer for American men despite clinical advancements. Currently, magnetic resonance imaging (MRI) is considered the most sensitive non-invasive imaging modality that enables visualization, detection, and localization of prostate cancer, and is increasingly used to guide targeted biopsies for prostate cancer diagnosis. However, its utility remains limited due to high rates of false positives and false negatives as well as low inter-reader agreements. Purpose: Machine learning methods to detect and localize cancer on prostate MRI can help standardize radiologist interpretations. However, existing machine learning methods vary not only in model architecture, but also in the ground truth labeling strategies used for model training. We compare different labeling strategies and the effects they have on the performance of different machine learning models for prostate cancer detection on MRI. Methods: Four different deep learning models (SPCNet, U-Net, branched U-Net, and DeepLabv3+) were trained to detect prostate cancer on MRI using 75 patients with radical prostatectomy, and evaluated using 40 patients with radical prostatectomy and 275 patients with targeted biopsy. Each deep learning model was trained with four different label types: pathology-confirmed radiologist labels, pathologist labels on whole-mount histopathology images, and lesion-level and pixel-level digital pathologist labels (previously validated deep learning algorithm on histopathology images to predict pixel-level Gleason patterns) on whole-mount histopathology images. The pathologist and digital pathologist labels (collectively referred to as pathology labels) were mapped onto pre-operative MRI using an automated MRI-histopathology registration platform. Results: Radiologist labels missed cancers (ROC-AUC: 0.75-0.84), had lower lesion volumes (~68% of pathology lesions), and lower Dice overlaps (0.24-0.28) when compared with pathology labels. Consequently, machine learning models trained with radiologist labels also showed inferior performance compared to models trained with pathology labels. Digital pathologist labels showed high concordance with pathologist labels of cancer (lesion ROC-AUC: 0.97-1, lesion Dice: 0.75-0.93). Machine learning models trained with digital pathologist labels had the highest lesion detection rates in the radical prostatectomy cohort (aggressive lesion ROC-AUC: 0.91-0.94), and had generalizable and comparable performance to pathologist label-trained-models in the targeted biopsy cohort (aggressive lesion ROC-AUC: 0.87-0.88), irrespective of the deep learning architecture. Moreover, machine learning models trained with pixel-level digital pathologist labels were able to selectively identify aggressive and indolent cancer components in mixed lesions on MRI, which is not possible with any human-annotated label type. Conclusions: Machine learning models for prostate MRI interpretation that are trained with digital pathologist labels showed higher or comparable performance with pathologist label-trained models in both radical prostatectomy and targeted biopsy cohort. Digital pathologist labels can reduce challenges associated with human annotations, including labor, time, inter- and intra-reader variability, and can help bridge the gap between prostate radiology and pathology by enabling the training of reliable machine learning models to detect and localize prostate cancer on MRI.

AI-assisted prostate cancer detection and localisation on biparametric MR by classifying radiologist-positives

Deep Attentive Panoptic Model for Prostate Cancer Detection Using Biparametric MRI Scans

Using an Artificial Intelligence Model to Detect and Localize Visible Clinically Significant Prostate Cancer in Prostate Magnetic Resonance Imaging: a Multicenter External Validation Study.

Deep learning-based artificial intelligence for prostate cancer detection at biparametric MRI

Deep learning model for the detection of prostate cancer and classification of clinically significant disease using multiparametric MRI in comparison to PI-RADs score

Autonomous Detection and Classification of PI-RADS Lesions in an MRI Screening Population Incorporating Multicenter-Labeled Deep Learning and Biparametric Imaging: Proof of Concept

Computer-aided detection of prostate cancer in early stages using multi-parameter MRI: A promising approach for early diagnosis

AI-predicted Mpmri Image Features for the Prediction of Clinically Significant Prostate Cancer.

Artificial intelligence for the diagnosis of clinically significant prostate cancer based on multimodal data: a multicenter study

Evaluation of a Cascaded Deep Learning-based Algorithm for Prostate Lesion Detection at Biparametric MRI

Prostate cancer inference via weakly-supervised learning using a large collection of negative MRI

Controlling False Positive/Negative Rates for Deep-Learning-Based Prostate Cancer Detection on Multiparametric MR images

Multimodal AI Combining Clinical and Imaging Inputs Improves Prostate Cancer Detection

[Advances in artificial intelligence-assisted MRI radiomics in the diagnosis and treatment of prostate cancer]

The Added Value of AI-based Computer-Aided Diagnosis in Classification of Cancer at Prostate MRI

External Validation of a Previously Developed Deep Learning-based Prostate Lesion Detection Algorithm on Paired External and In-House Biparametric MRI Scans

Bridging the gap between prostate radiology and pathology through machine learning

Deep Learning in Prostate Cancer Diagnosis Using Multiparametric Magnetic Resonance Imaging With Whole-Mount Histopathology Referenced Delineations

A multicenter study of artificial intelligence-aided software for detecting visible clinically significant prostate cancer on mpMRI

Automated diagnosis of prostate cancer in multi-parametric MRI based on multimodal convolutional neural networks

Deep‐Learning‐Based Artificial Intelligence for PI‐RADS Classification to Assist Multiparametric Prostate MRI Interpretation: A Development Study